why choose us

First received: October 25, 2022

Clinical Trial: Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure

Study Status: Completed

Recruit Status: RECRUITING

Condition: Congestive Heart Failure

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Adaptive, Double-blinded, Placebo Controlled, Randomized, Multi-center Trial to Evaluate the Efficacy, Safety and Tolerability of Intracoronary Infusion of AB-1002 in Adult Subjects With Ne

Brief Summary: This is a Phase 2 adaptive, double-blinded, placebo-controlled, randomized, multi-center trial study to evaluate the safety and efficacy of a single dose of AB-1002, administered via antegrade intracoronary artery infusion, in males and females age >18 years with non-ischemic cardiomyopathy and NYHA Class III symptoms of HF.Subjects will be randomized into one of three treatment groups in a 1:1:1

Read more